Hikari Okita is co-founder of PeptiDream, a Japanese biotech company leveraging research from the University of Tokyo to discover and develop non-standard peptide therapeutics. The company has formed global partnerships and become one of Japan’s most valuable biotech firms.
Know a leader or enterprise like this? Nominate them for Transformational Leaders & Enterprises™, in Dubai, Barcelona or London.
Editorial profile compiled from public sources. Facts are confirmed with the subject before the profile is expanded, and the subject may request corrections at ceo@gceip.com.